Navigation Links
NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
Date:6/10/2008

IV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions, that the Company believes offers significant advantages over other pain therapies. NeurogesX' marketing authorization application (MAA) to the European Medicines Agency (EMEA) was accepted for review in September 2007 and NeurogesX plans to file a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) in 2008 for PHN.

Safe Harbor Statement

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). NeurogesX disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include, but are not limited to, the expected benefits of NeurogesX' lead product candidate, NGX-4010. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to, NeurogesX' product candidate may have unexpected adverse side effects or inadequate therapeutic efficacy; positive results in clinical trials may not be sufficient to obtain FDA or European regulatory approval; physician or patient reluctance to use NGX-4010, if approved, or the inability of physicians to obtain sufficient reimbursement for such procedures; potential alternative therapies; maintaining adequate patent or trade secret protection without violating the intellectual property rights of others; and other difficulties or delays in clinical development, obtaining regulatory approval, market acceptance and commercialization of NGX-4010 and the advantages of NGX-4010 over other pain therapies. For further information regarding these and other risks rel
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
2. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
3. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
4. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
5. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
6. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
7. ASPIRE Independent Review Board Announces 10 Ways to Protect Participants Rights in Clinical Drug Trials and Optimize Results From Research
8. Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent
9. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
10. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
11. Anpath Group, Inc. Announces Addition of MRSA and VRE Claims for Its EnviroTru(R) Disinfectant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... N.J. , Sept. 15, 2014   Hudson ... , in cooperation with Johns Hopkins University , ... a commercially viable high-throughput screening (HTS) system for ... Logo - http://photos.prnewswire.com/prnh/20140912/145910 This ... (ARQiv) system, will bring high-throughput screening technology into ...
(Date:9/15/2014)... 2014 ResMed today announced that its AirView ... connected to Fairview Health Services, Epic EHR system, enabling ... for use by Fairview,s medical staff. Launched in June ... reduced cost, improved quality and responsiveness of therapy, and ... decision support. Sleep apnea occurs when ...
(Date:9/15/2014)... Organovo Holdings, Inc. (NYSE MKT: ... regenerative medicine company focused on using its breakthrough NovoGen ... demand for medical research and therapeutic applications, today announced that ... now available for on-demand viewing at RetailInvestorConferences.com. Attendees can ... well as an update on the company recorded during ...
Breaking Medicine Technology:Hudson Robotics and Johns Hopkins Receive NIH Grant for Zebrafish HTS System 2ResMed and Fairview Health Services Introduce Integration of Sleep and Respiratory Therapy Data into EHR System 2ResMed and Fairview Health Services Introduce Integration of Sleep and Respiratory Therapy Data into EHR System 3ResMed and Fairview Health Services Introduce Integration of Sleep and Respiratory Therapy Data into EHR System 4Organovo Holdings, Inc.'s Presentations Now Available for On-Demand viewing at RetailInvestorConferences.com 2Organovo Holdings, Inc.'s Presentations Now Available for On-Demand viewing at RetailInvestorConferences.com 3
... Dec. 21, 2010 Generational Equity, a leading ... mergers, acquisitions, strategic growth initiatives, business valuation and ... B-Pharm, Inc. dba Remedies Pharmacy, headquartered in Carrollton, ... closed on October 26, 2010.  Managing Director, Terry ...
... Dec. 21, 2010 Zimmer Holdings, Inc. (NYSE and ... announced that it has completed the acquisition of Beijing ... Zimmer,s presence in the emerging Chinese market.   ... Zimmer family," said David C. Dvorak, President and CEO ...
Cached Medicine Technology:Generational Equity Announces Sale of B-Pharm, Inc. dba Remedies Pharmacy to a Private Investment Group 2Zimmer Finalizes Acquisition of Chinese Orthopaedic Implant Leader Beijing Montagne Medical Device Co., Ltd. 2
(Date:9/15/2014)... (PRWEB) September 15, 2014 Ondine ... Nicolas Loebel, its President and Chief Technology Officer, ... on Photodynamic Therapy (PDT) and Photodiagnosis in Clinical ... in Brixen/Bressanone (Italy) from October 14-18, 2014 alongside ... Medicine on October 13-14th, is an annual conference ...
(Date:9/15/2014)... 2014 (HealthDay News) -- U.S. heart experts recommend doctors ... when evaluating young people for underlying heart disease that ... Heart Association and the American College of Cardiology said ... and family medical history along with a physical examination ... (existing from birth) risks for sudden cardiac death. ...
(Date:9/15/2014)... (PRWEB) September 16, 2014 “Canada ... market data on the Canada Gynecological Devices market. ... dollars, volume (in units) and average prices (in ... Female Sterilization Devices (Transcervical Sterilization Devices ... Rings) , Endometrial Ablation Devices (Thermal ...
(Date:9/15/2014)... HealthDay Reporter MONDAY, ... about twice as often as they,re actually needed for ... indicates. More than 11 million antibiotic prescriptions written ... according to researchers from University of Washington and Seattle ... to eradicate children,s viral illnesses, researchers said, but supports ...
(Date:9/15/2014)... As Colorado's historic experiment with legalized, ... year, there are a variety of signs the ... of its marketing and branding. , One sure ... Kindman, one of the state's most established and ... pioneered the first-ever branded and pre-packaged line of ...
Breaking Medicine News(10 mins):Health News:Ondine Presenting at the 2014 International Symposium on Photodynamic Therapy and Photodiagnosis 2Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 2Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 2Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 4Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 2Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 3Health News:Colorado Company Unveils Innovative Line of Pre-packaged Cannabis Products 2Health News:Colorado Company Unveils Innovative Line of Pre-packaged Cannabis Products 3
... , ZURICH , Jan. 25 The Starr ... to two humanitarian organizations providing critical relief in Haiti . ... support efforts to deliver much-needed medical care, clean water and sanitation ... $750,000 grant to Partners in Health (PIH) to help ...
... , , WASHINGTON ... an unsafe, counterfeit version of the weight-loss drug Alli sold over ... tests showed that the counterfeit Alli has a different active ingredient, ... counterfeit Alli may be taking three times the usual ...
... shows that acyclovir, a commonly prescribed drug used to suppress ... by people with both viruses. The study, conducted ... by the New England Journal of Medicine in ... print edition Feb. 4. The largest risk group ...
... ... Orange Israel Telecommunications have announced today that they are aiding humanitarian efforts in ... be the first of three stages of establishing the orphanage which is expected ... be providing fresh, running drinking water, an electric generator, tents and primary medical ...
... WASHINGTON , Jan. 25 In an effort ... is currently accepting applications for its 2010 Advocates in Disability Award, ... 26 in the Washington, DC Metropolitan area who is ... on their current and previous work that impacts people with disabilities, ...
... , NEW YORK , ... of the 25 largest PR firms ( http://www.5wpr.net/ ) in the U.S., today ... its versatile roster of fashion and lifestyle clients. Launched in 2002, the luxury ... lifestyle products using proprietary natural frequency technology. , " Philip Stein is ...
Cached Medicine News:Health News:Starr International Foundation Gives $1 Million To Earthquake Relief Effort In Haiti 2Health News:FDA CONSUMER HEALTH INFORMATION: FDA Warns Consumers About Unsafe Counterfeit Alli 2Health News:Control of herpes symptoms does not reduce HIV transmission, international study found 2Health News:Israel Flying Aid, Orange Israel Create Haiti Orphanage, Provide Humanitarian Aid 2Health News:Israel Flying Aid, Orange Israel Create Haiti Orphanage, Provide Humanitarian Aid 3Health News:Israel Flying Aid, Orange Israel Create Haiti Orphanage, Provide Humanitarian Aid 4Health News:DC Nonprofit Searches for Next Generation of Disability Advocates 2Health News:5W Public Relations Adds Philip Stein Watches to Its Fashion & Lifestyle Client Roster 2Health News:5W Public Relations Adds Philip Stein Watches to Its Fashion & Lifestyle Client Roster 3
... for small and large multi-specialty provider networks. ... check-out. Review the complete Patient History, from ... labs and charts all by one click ... immediately. Communicate electronically with the referring physicians ...
The best value and features offered in a complete EMR and Practice Management Solution...
... Written specifically for urologists by ... utilizes touch screen technology to ... eliminate the use of a ... makes using an EMR faster ...
... The MediNotes Content Department has worked ... comprehensive medical content library and exam templates ... Plus is one of the most flexible ... which will allow you to take the ...
Medicine Products: